Uncategorized
RIDE/RISE: Ranibizumab outperforms sham for treatment of DME
Ranibizumab improved visual acuity and patient-reported visual function among patients with diabetic macular edema, according to study findings.Researchers analyzed data from 382 patients in the RIDE study and 377 patients in the RISE study.